1. Home
  2. CDW vs BNTX Comparison

CDW vs BNTX Comparison

Compare CDW & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CDW Corporation

CDW

CDW Corporation

HOLD

Current Price

$121.54

Market Cap

15.5B

ML Signal

HOLD

Logo BioNTech SE

BNTX

BioNTech SE

HOLD

Current Price

$88.85

Market Cap

22.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CDW
BNTX
Founded
1984
2008
Country
United States
Germany
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.5B
22.8B
IPO Year
2013
2019

Fundamental Metrics

Financial Performance
Metric
CDW
BNTX
Price
$121.54
$88.85
Analyst Decision
Buy
Strong Buy
Analyst Count
8
13
Target Price
$164.88
$134.15
AVG Volume (30 Days)
1.3M
1.3M
Earning Date
05-06-2026
03-10-2026
Dividend Yield
2.07%
N/A
EPS Growth
1.38
N/A
EPS
8.08
N/A
Revenue
$10,768,600,000.00
N/A
Revenue This Year
$4.08
N/A
Revenue Next Year
$4.01
$4.76
P/E Ratio
$15.11
N/A
Revenue Growth
6.32
N/A
52 Week Low
$112.98
$79.81
52 Week High
$189.45
$124.00

Technical Indicators

Market Signals
Indicator
CDW
BNTX
Relative Strength Index (RSI) 47.32 37.88
Support Level $119.14 $79.81
Resistance Level $127.29 $113.12
Average True Range (ATR) 3.54 2.84
MACD 0.69 -0.42
Stochastic Oscillator 68.17 39.10

Price Performance

Historical Comparison
CDW
BNTX

About CDW CDW Corporation

CDW Corp is a multi-brand provider of information technology (IT) solutions to businesses, government, education, and healthcare customers in the United States, the United Kingdom, and Canada. The company's offerings range from hardware and software products to integrated IT solutions and services, including on-premise and cloud capabilities across hybrid infrastructure, digital experience, and security. Its reportable segments are Corporate, Small Business, Public, and Other. The Corporate and Small Business segments serve US private sector business customers, while the Public segment consists of government agencies and education and healthcare institutions in the US. The Corporate segment generates the majority of its revenue in the United States.

About BNTX BioNTech SE

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.

Share on Social Networks: